药品注册申请号:203016
申请类型:ANDA (仿制药申请)
申请人:TORRENT
申请人全名:TORRENT PHARMACEUTICALS LTD
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 TOLTERODINE TARTRATE TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 2MG No No AB 2015/08/11 2015/08/11 Prescription
002 TOLTERODINE TARTRATE TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 4MG No No AB 2015/08/11 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2020/03/09 SUPPL-3(补充) Approval Labeling STANDARD
2015/08/11 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:TOLTERODINE TARTRATE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:2MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021228 001 NDA DETROL LA TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 2MG Prescription Yes No AB 2000/12/22 UPJOHN
203016 001 ANDA TOLTERODINE TARTRATE TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 2MG Prescription No No AB 2015/08/11 TORRENT
079141 001 ANDA TOLTERODINE TARTRATE TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 2MG Prescription No No AB 2016/11/22 TEVA PHARMS USA
206419 001 ANDA TOLTERODINE TARTRATE TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 2MG Prescription No No AB 2017/12/12 HETERO LABS LTD III
204562 001 ANDA TOLTERODINE TARTRATE TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 2MG Prescription No No AB 2019/08/19 INVENTIA HLTHCARE
213397 001 ANDA TOLTERODINE TARTRATE TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 2MG Prescription No No AB 2020/05/19 AJANTA PHARMA LTD
213858 001 ANDA TOLTERODINE TARTRATE TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 2MG Prescription No No AB 2021/02/02 UTOPIC PHARMS
216917 001 ANDA TOLTERODINE TARTRATE TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 2MG Prescription No No AB 2024/08/27 UNICHEM
活性成分:TOLTERODINE TARTRATE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:4MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021228 002 NDA DETROL LA TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 4MG Prescription Yes Yes AB 2000/12/22 UPJOHN
203016 002 ANDA TOLTERODINE TARTRATE TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 4MG Prescription No No AB 2015/08/11 TORRENT
079141 002 ANDA TOLTERODINE TARTRATE TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 4MG Prescription No No AB 2016/11/22 TEVA PHARMS USA
206419 002 ANDA TOLTERODINE TARTRATE TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 4MG Prescription No No AB 2017/12/12 HETERO LABS LTD III
204562 002 ANDA TOLTERODINE TARTRATE TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 4MG Prescription No No AB 2019/08/19 INVENTIA HLTHCARE
213397 002 ANDA TOLTERODINE TARTRATE TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 4MG Prescription No No AB 2020/05/19 AJANTA PHARMA LTD
213858 002 ANDA TOLTERODINE TARTRATE TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 4MG Prescription No No AB 2021/02/02 UTOPIC PHARMS
216917 002 ANDA TOLTERODINE TARTRATE TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE;ORAL 4MG Prescription No No AB 2024/08/27 UNICHEM
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database